We recently held an interactive symposium with international experts discussing overcoming common challenges encountered in the diagnosis of rare bone diseases at ECE 2022 in Milan. Access the educational resources now, including a recording of the full symposium and an interactive Q&A session. Downloadable slide content is also available.

 

International rare bone disease experts shared their perspectives and experiences on common challenges encountered in the diagnosis of rare bone diseases, with a focus on:

  • Fibrodysplasia ossificans progressiva
  • FGF23-related hypophosphatemic rickets/osteomalacia
  • Hypophosphatasia

Prof. Dr. Maria Luisa Brandi is a Professor of Endocrinology at the Vita-Salute University at the San Raffaele, Milan, Italy. She is President of the FIRMO Foundation, a non-profit research organization fully devoted to skeletal health.

 

Her research and fellowship has received several awards and honors, such as Roussel Italia Award, 1988; The European Foundation Award, 1989; Schering Award, Italian Endocrine Society, 1990; The Sandoz Foundation for Gerontological Research Award, 1991; Helena Rubinstein Award “Women in Science”, 1998; Italian Endocrine Society Senior Award, 2003; AILA Award, 2004, Pierre Delmas IOF/ESCEO Prize 2013.

 

Her research includes Genetics and Clinics of Osteoporosis; Pathogenesis of Parathyroid Disorders; Genetics of Paget’s Disease of Bone; Bone Cell Biology; Epidemiology of Osteoporosis; Bone Inherited Disorders. She is serving as an editorial member of several reputed journals like Clinical Cases in Bone and Mineral Metabolism, Journal of Bone and Mineral Research, Medicine, etc. She has authored over 500 papers in peerly reviewed journals and 200 chapters and books. She is a member of American Association of Clinical Endocrinologists; Endocrine Society; International Bone and Mineral Society; Italian Society of Endocrinology; Italian Society of Internal Medicine; International Multiple Endocrine Neoplasia Committee.

Programme summary
Access ECE on demand
Share this programme
This educational programme is supported by an Independent Educational Grant from Ipsen, Kyowa Kirin and Alexion.
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Ipsen, Kyowa Kirin and Alexion.
I agree that this educational programme:

Was valuable to me

1/4

Other programmes of interest

conference-update Conference update

Episode

2

of 2

episode
Oncology Rare diseases Endocrinology 
Actualités du Congrès l’ENETS 2026

Points de vue d’experts sur les dernières données concernant le cancer neuroendocrinien

Experts
Prof. Louis de Mestier, Prof. Timon Vandamme, Dr Alice Durand
  • clock 5 MIN
  • calendar Mar 2026
  • Non-accredited Independent Medical Education

Cette vidéo est soutenue par une subvention indépendante à visée éducative d’Ipsen.  Les contenus publiés sur ce site internet sont sous la responsabilité de leurs auteurs. Certaines données scientifiques publiées sur ce site sont susceptibles de ne pas être validées par la commission d’Autorisation de Mise sur le Marché, et ne doivent pas être mises en pratique. Elles doivent être lues et comprises avec le plus grand discernement et sont données dans leur cadre de la diffusion de l’information sur l’état actuel de la recherche auprès de la communauté scientifique internationale  
conference-update Conference update

Episode

1

of 2

episode
Oncology Rare diseases Endocrinology 
Update from ENETS 2026

Experts share their views on latest data in neuroendocrine cancer

Experts
Prof. Louis de Mestier, Prof. Timon Vandamme, Dr Alice Durand
  • clock 5 MIN
  • calendar Mar 2026
  • Non-accredited Independent Medical Education

This educational programme is supported by an Independent Educational Grant from Ipsen. The content published on this website is under the responsibility of its authors. Some scientific data published on this website may not have been validated by the relevant Marketing Authorisation Committees and should not be put into practice. It should be read and understood with the utmost discernment and is provided for the purpose of disseminating information on the current state of research to the international scientific community.
patient-support Patient Support
Rare diseases 
Understanding narcolepsy

Persistent sleepiness: when to look closer

Experts
Prof. Yves Dauvilliers
Endorsed by
EU-NN ANC
eNAP
  • clock 2 MIN
  • calendar Jan 2026
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Takeda
patient-support Patient Support

Episode

2

of 2

episode
Oncology Endocrinology Rare diseases 
Thriving beyond an EP-NEC diagnosis

Perspectives on treatment and care 

Experts
Jessica Thomas
Endorsed by
NET-Research-Foundation Minkhas mission
  • clock 4 MIN
  • calendar Dec 2025
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Boehringer Ingelheim 
patient-support Patient Support

Episode

1

of 2

episode
Oncology Endocrinology Rare diseases 
Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC)

Insights for patients and care partners 

Experts
Meredith Cummins
Endorsed by
INCA
NeuroEndocrine Cancer Australia Neuroendocrine Cancer Foundation NET-Research-Foundation
Neuroendocrine Cancer UK Minkhas mission
  • clock 5 MIN
  • calendar Dec 2025
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Boehringer Ingelheim 
podcast Video podcast
Oncology Endocrinology Rare diseases 
Understanding EP-NEC: Through diagnosis, treatment, and support

A medical oncologist and a patient advocate share their perspectives

Experts
Dr Aman Chauhan, Susan Meckler-Plummer, RN
Endorsed by
Minkhas mission Neuroendocrine Cancer UK Neuroendocrine Cancer Foundation
NET-Research-Foundation
  • download Downloadable
    Resources
  • clock 27 MIN
  • calendar Nov 2025
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Boehringer Ingelheim